A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: Analysis of risk factors for clinical outcome

Patrick Stiff*, Robert Bayer, Maria Camarda, Sally Tan, James Dolan, Ronald Potkul, Saoud Loutfi, Laura Kinch, Jeff Sosman, David Peace, Nancy Rad, R. Scott McKenzie

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: Analysis of risk factors for clinical outcome'. Together they form a unique fingerprint.

Medicine & Life Sciences